Marvell (MRVL) PT Raised to $70 at Stifel Into Earnings Results

Marvell (MRVL) PT Raised to $72 at Susquehanna Into Earnings

Susquehanna analyst Christopher Rolland raised the price target on Marvell (NASDAQ: MRVL) to $72.00 (from $64.00) while maintaining a Positive rating ahead of results on Thursday.

The analyst commented, "On Thursday, Aug. 26, Marvell will report its C2Q21 results and C3Q21 guidance. Given recent M&A (Inphi, Avera, Aquantia, and soon Innovium), we note it has become more difficult to predict each segment, but offer our best efforts approach. In addition, it should be noted management plans to introduce new segment breakouts this report, based on five end markets. In short, we expect modest... More

Marvell (MRVL) PT Raised to $70 at BMO Capital

BMO Capital analyst Ambrish Srivastava raised the price target on Marvell (NASDAQ: MRVL) to $70.00 (from $60.00) while maintaining a Outperform rating.

Marvell (MRVL) PT Raised to $55 at Cowen

Cowen analyst Karl Ackerman raised the price target on Marvell (NASDAQ: MRVL) to $55.00 (from $50.00) while maintaining a Market Perform rating.

Morgan Stanley Raises Marvell (MRVL) PT to $57 Ahead of Earnings

Morgan Stanley analyst Joseph Moore raised the price target on Marvell (NASDAQ: MRVL) to $57.00 (from $49.00) while maintaining a Equalweight rating ahead of earnings on Thursday, August 26th after the close.

The analyst stated "The company guided for a robust low double... More

Marvell (MRVL) PT Raised to $72 at B.Riley

B.Riley analyst Craig Ellis raised the price target on Marvell (NASDAQ: MRVL) to $72.00 (from $66.00) while maintaining a Buy rating.... More

Marvell (MRVL) PT Raised to $70 at Oppenheimer

Oppenheimer analyst Rick Shafer raised the price target on Marvell (NASDAQ: MRVL) to $70.00 (from $60.00) while maintaining a Outperform rating.... More